Gibbs Michael Terrence 4/A
4/A · T2 Biosystems, Inc. · Filed Apr 5, 2023
Insider Transaction Report
Form 4/AAmended
Gibbs Michael Terrence
General Counsel
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-03-24−334→ 0 total→ Common Stock (334 underlying) - Exercise/Conversion
Common Stock
2023-03-24+334→ 6,851 total
Footnotes (3)
- [F1]The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021